Paul A. Laviolette's most recent trade in Pulse Biosciences Inc was a trade of 15,000 Common Stock done at an average price of $19.7 . Disclosure was reported to the exchange on May 11, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Pulse Biosciences Inc | Paul A. Laviolette | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 19.69 per share. | 11 May 2026 | 15,000 | 15,846 (0%) | 0% | 19.7 | 295,350 | Common Stock |
| Edwards Lifesciences | Paul A. Laviolette | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2026 | 3,251 | 17,552 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences | Paul A. Laviolette | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2025 | 3,528 | 14,301 (0%) | 0% | 0 | Common Stock | |
| Pulse Biosciences Inc | Paul A. Laviolette | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2025 | 1,050,000 | 1,050,000 | - | - | Stock Option (right to buy) | |
| Pulse Biosciences Inc | Paul A. Laviolette | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2025 | 450,000 | 450,000 | - | - | Stock Option (right to buy) | |
| Pulse Biosciences Inc | Paul A. Laviolette | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2024 | 200,000 | 200,000 | - | - | Stock Option (right to buy) | |
| Pulse Biosciences Inc | Paul A. Laviolette | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2024 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Edwards Lifesciences | Paul A. Laviolette | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 3,055 | 10,773 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences | Paul A. Laviolette | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2023 | 2,803 | 7,718 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences | Paul A. Laviolette | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2022 | 2,300 | 4,915 (0%) | 0% | 0 | Common Stock |